LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 318 of 535
Next
>>
>
7926 to 7950 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	TWS119	0.12	uM	LJP5	3	M05	72	hr	1097	3717	3925	0.9469	0.9415
BT-20	TWS119	0.37	uM	LJP5	1	M04	72	hr	1097	3207	3735	0.8586	0.8347
BT-20	TWS119	0.37	uM	LJP5	2	M04	72	hr	1097	4067	3877	1.0488	1.0530
BT-20	TWS119	0.37	uM	LJP5	3	M04	72	hr	1097	3422	3925	0.8718	0.8562
BT-20	TWS119	1.11	uM	LJP5	1	M03	72	hr	1097	2487	3735	0.6658	0.5888
BT-20	TWS119	1.11	uM	LJP5	2	M03	72	hr	1097	3491	3877	0.9003	0.8879
BT-20	TWS119	1.11	uM	LJP5	3	M03	72	hr	1097	3261	3925	0.8307	0.8082
BT-20	TWS119	3.33	uM	LJP5	1	M02	72	hr	1097	2137	3735	0.5721	0.4582
BT-20	TWS119	3.33	uM	LJP5	2	M02	72	hr	1097	2581	3877	0.6656	0.5994
BT-20	TWS119	3.33	uM	LJP5	3	M02	72	hr	1097	2910	3925	0.7413	0.6996
BT-20	TWS119	10	uM	LJP5	1	M01	72	hr	1097	828	3735	0.2217	-0.1473
BT-20	TWS119	10	uM	LJP5	2	M01	72	hr	1097	1155	3877	0.2979	0.0286
BT-20	TWS119	10	uM	LJP5	3	M01	72	hr	1097	1465	3925	0.3732	0.1702
BT-20	PF477736	0.04	uM	LJP5	1	J24	72	hr	1097	3500	3735	0.9370	0.9277
BT-20	PF477736	0.04	uM	LJP5	2	J24	72	hr	1097	3451	3877	0.8899	0.8760
BT-20	PF477736	0.04	uM	LJP5	3	J24	72	hr	1097	3736	3925	0.9517	0.9469
BT-20	PF477736	0.12	uM	LJP5	1	J23	72	hr	1097	3646	3735	0.9761	0.9728
BT-20	PF477736	0.12	uM	LJP5	2	J23	72	hr	1097	3621	3877	0.9338	0.9262
BT-20	PF477736	0.12	uM	LJP5	3	J23	72	hr	1097	3596	3925	0.9161	0.9069
BT-20	PF477736	0.37	uM	LJP5	1	J22	72	hr	1097	3581	3735	0.9587	0.9529
BT-20	PF477736	0.37	uM	LJP5	2	J22	72	hr	1097	3629	3877	0.9358	0.9285
BT-20	PF477736	0.37	uM	LJP5	3	J22	72	hr	1097	3884	3925	0.9895	0.9885
BT-20	PF477736	1.11	uM	LJP5	1	J21	72	hr	1097	3514	3735	0.9408	0.9321
BT-20	PF477736	1.11	uM	LJP5	2	J21	72	hr	1097	3752	3877	0.9676	0.9641
BT-20	PF477736	1.11	uM	LJP5	3	J21	72	hr	1097	3874	3925	0.9869	0.9857

|<
<<
Previous
Page 318 of 535
Next
>>
>
7926 to 7950 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)